Cholesterol lowering drug 'increases risk of cancer by 50 per cent' - The Telegraph 3rd September 2008

A cholesterol-lowering drug may increase the risk of cancer by half, according to new findings. Researchers found there were 105 cases of cancer in people taking Inegy compared to 70 in those on a dummy drug over a four year period. The study also suggested that Inegy, which combines a statin called simvastatin and another drug called ezetimibe, has little effect in reducing the risk of heart attacks and strokes.

Link to Article

Additional Story

Cholesterol pill warning: Scientists raise fears of cancer link to statin used by thousands - Daily Mail 3rd September 2008